• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于导航的远程医疗决策支持系统在黑人男性前列腺癌筛查中的应用

Navigation-Based Telehealth Informed Decision-Making for Prostate Cancer Screening in Black Men.

机构信息

Department of Public Health Sciences, Penn State College of Medicine, Hershey, PA 17033, USA.

Department of Urology, Penn State College of Medicine, Hershey, PA 17033, USA.

出版信息

Curr Oncol. 2024 Jun 28;31(7):3698-3712. doi: 10.3390/curroncol31070273.

DOI:10.3390/curroncol31070273
PMID:39057145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11275421/
Abstract

The rapid increase in telehealth has the potential to bring informed decision-making for prostate cancer screening (PCS) at the population level to high-risk individuals. We utilized a global technology platform of electronic health records data repositories (TriNetX) to determine its utility for Navigator-guided decision-making aid for PCS in Black men ages 45-79 years with no history of prostate cancer and PSA testing. Patients from Pennsylvania were invited to participate in a telehealth-delivered informed decision-making session for PCS. Focus groups, social learning theory, visual diagrams, and quantitative data on PCS risks and benefits were used to develop the content of the sessions, which included numerical discussions of risks vs. benefits in Black men. Participants completed several surveys, including baseline demographic and numeracy questionnaires, a one-on-one telehealth session with a trained Navigator, post-Navigation surveys, and an optional follow-up session with a urologist. Eighty-seven participants were consented and recruited. Although the mean numeracy score was only 1.9 out of 6, more than 90% rated as good or excellent that the sessions aided their PCS decision-making skills. This study indicates that Navigation by telehealth offers the ability to assist in informed decision-making for PCS at the population level.

摘要

远程医疗的迅速发展有可能将前列腺癌筛查(PCS)的知情决策提升到高危人群的水平。我们利用全球电子健康记录数据存储库(TriNetX)技术平台,确定其在为 45-79 岁无前列腺癌和 PSA 检测史的黑人男性提供导航员指导的 PCS 决策辅助方面的效用。宾夕法尼亚州的患者受邀参加远程医疗提供的 PCS 知情决策会议。我们使用焦点小组、社会学习理论、可视化图表以及关于 PCS 风险和益处的定量数据来开发会议内容,其中包括对黑人男性风险与益处的数值讨论。参与者完成了几项调查,包括基线人口统计学和计算能力问卷、与经过培训的导航员进行的一对一远程医疗会议、导航后调查以及与泌尿科医生进行的可选随访会议。共同意并招募了 87 名参与者。尽管平均计算能力得分仅为 6 分中的 1.9 分,但超过 90%的参与者表示,这些会议有助于他们做出 PCS 决策。这项研究表明,通过远程医疗进行导航有助于在人群水平上进行 PCS 的知情决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62b5/11275421/0f451293ba4f/curroncol-31-00273-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62b5/11275421/250ff0581076/curroncol-31-00273-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62b5/11275421/0f451293ba4f/curroncol-31-00273-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62b5/11275421/250ff0581076/curroncol-31-00273-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/62b5/11275421/0f451293ba4f/curroncol-31-00273-g002.jpg

相似文献

1
Navigation-Based Telehealth Informed Decision-Making for Prostate Cancer Screening in Black Men.基于导航的远程医疗决策支持系统在黑人男性前列腺癌筛查中的应用
Curr Oncol. 2024 Jun 28;31(7):3698-3712. doi: 10.3390/curroncol31070273.
2
Evaluating a Prostate Cancer Education and Navigation to Screening Program for Black Men in South Carolina, U.S.评估美国南卡罗来纳州针对黑人男性的前列腺癌教育与筛查引导项目
Cancer Control. 2025 Jan-Dec;32:10732748251364046. doi: 10.1177/10732748251364046. Epub 2025 Aug 6.
3
Randomized trial of community health worker-led decision coaching to promote shared decision-making for prostate cancer screening among Black male patients and their providers.由社区卫生工作者主导的决策指导促进黑人男性患者及其医疗服务提供者共同参与前列腺癌筛查决策的随机试验。
Trials. 2021 Feb 10;22(1):128. doi: 10.1186/s13063-021-05064-4.
4
Screening for prostate cancer.前列腺癌筛查
Cochrane Database Syst Rev. 2013 Jan 31;2013(1):CD004720. doi: 10.1002/14651858.CD004720.pub3.
5
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
6
Understanding Barriers to Engagement With a Prostate Cancer Research and Genetic Risk Service Among UK Men of Black African or Black Caribbean Ancestry.了解英国非洲裔或加勒比裔黑人男性参与前列腺癌研究和遗传风险服务的障碍。
Health Expect. 2025 Jun;28(3):e70282. doi: 10.1111/hex.70282.
7
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
8
Decision aids for people facing health treatment or screening decisions.为面临医疗治疗或筛查决策的人们提供的决策辅助工具。
Cochrane Database Syst Rev. 2011 Oct 5(10):CD001431. doi: 10.1002/14651858.CD001431.pub3.
9
Decision aids for people facing health treatment or screening decisions.为面临健康治疗或筛查决策的人群提供的决策辅助工具。
Cochrane Database Syst Rev. 2014 Jan 28(1):CD001431. doi: 10.1002/14651858.CD001431.pub4.
10
Outcomes of specialist physiotherapy for functional motor disorder: the Physio4FMD RCT.功能性运动障碍专科物理治疗的效果:Physio4FMD随机对照试验
Health Technol Assess. 2025 Jul;29(34):1-28. doi: 10.3310/MKAC9495.

本文引用的文献

1
Prostate-Specific Antigen Screening and 15-Year Prostate Cancer Mortality: A Secondary Analysis of the CAP Randomized Clinical Trial.前列腺特异性抗原筛查与 15 年前列腺癌死亡率:CAP 随机临床试验的二次分析。
JAMA. 2024 May 7;331(17):1460-1470. doi: 10.1001/jama.2024.4011.
2
A global federated real-world data and analytics platform for research.一个用于研究的全球联合真实世界数据与分析平台。
JAMIA Open. 2023 May 13;6(2):ooad035. doi: 10.1093/jamiaopen/ooad035. eCollection 2023 Jul.
3
Prostate cancer screening: Continued controversies and novel biomarker advancements.
前列腺癌筛查:持续的争议与新型生物标志物进展
Curr Urol. 2022 Dec;16(4):197-206. doi: 10.1097/CU9.0000000000000145. Epub 2022 Aug 31.
4
Leveraging Telehealth for the Management of Breast Cancer: A Systematic Review.利用远程医疗管理乳腺癌:一项系统综述。
Healthcare (Basel). 2022 Oct 12;10(10):2015. doi: 10.3390/healthcare10102015.
5
Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incidence at US Veterans Health Administration Facilities.美国退伍军人事务部医疗机构中前列腺特异性抗原筛查率与随后发生转移性前列腺癌发病率的相关性。
JAMA Oncol. 2022 Dec 1;8(12):1747-1755. doi: 10.1001/jamaoncol.2022.4319.
6
Racial disparities in Black men with prostate cancer: A literature review.黑人男性前列腺癌中的种族差异:文献综述。
Cancer. 2022 Nov 1;128(21):3787-3795. doi: 10.1002/cncr.34433. Epub 2022 Sep 6.
7
Survey of cancer screening practices and telehealth services among primary care physicians during the COVID-19 pandemic.新冠疫情期间基层医疗医生的癌症筛查实践与远程医疗服务调查
Prev Med Rep. 2022 Mar 17;27:101769. doi: 10.1016/j.pmedr.2022.101769. eCollection 2022 Jun.
8
Racial and Ethnic Disparities in Prostate Cancer Outcomes in the Veterans Affairs Health Care System.退伍军人事务部医疗保健系统中前列腺癌结局的种族和民族差异。
JAMA Netw Open. 2022 Jan 4;5(1):e2144027. doi: 10.1001/jamanetworkopen.2021.44027.
9
Effectiveness of Patient Navigation to Increase Cancer Screening in Populations Adversely Affected by Health Disparities: a Meta-analysis.患者导航对增加受健康差异负面影响人群癌症筛查的效果:一项荟萃分析。
J Gen Intern Med. 2020 Oct;35(10):3026-3035. doi: 10.1007/s11606-020-06020-9. Epub 2020 Jul 22.
10
Prostate Cancer Incidence and Aggressiveness in Appalachia versus Non-Appalachia Populations in Pennsylvania by Urban-Rural Regions, 2004-2014.宾夕法尼亚州城乡地区 2004-2014 年阿巴拉契亚地区与非阿巴拉契亚地区前列腺癌发病和侵袭性比较。
Cancer Epidemiol Biomarkers Prev. 2020 Jul;29(7):1365-1373. doi: 10.1158/1055-9965.EPI-19-1232. Epub 2020 Apr 10.